Search Resources (English): Women and Health Protection (WHP)

Results 21 - 30 of 63

Results

Same tune, different lyrics: the Vioxx story  
http://www.cwhn.ca/node/39500
Illustrates the flaws in the Canadian drug approval and drug regulatory processes, using the current Vioxx scandal as example. (See Details)
Published: 2005
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross secti  
http://bmj.bmjjournals.com/cgi/content/full/324/7332/278
Examines the relation between direct to consumer advertising and patients' requests for prescriptions and the relation between patients' requests and prescribing decisions. (See Details)
Published: 2002
Remembering Ruth Cooperstock: women and pharmaceuticals 20 years later  
http://www.whp-apsf.ca/pdf/coopProceedingsEN.pdf
Presents the proceedings of a symposium that examined women and the pharmaceuticals industry. Includes presentations of the three panellists and a brief summary of each of the workshops. (See Details)
Published: 2006
Drugs in our water: chronic exposure to chemicals in water supply may be harmful to health  
http://www.cwhn.ca/node/39540
Explores the issue of trace amounts of pharmaceutical drugs that can enter our drinking water from lakes, rivers, streams and groundwater. (See Details)
Published: 2003
International harmonisation of pharmaceuticals: key issues of concern for public health  
http://www.whp-apsf.ca/en/documents/harmon.html
Focuses on the activities and implications of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Identifies specific areas of concern for public health and the public interest in the realisation of health. (See Details)
Published: 2001
The inclusion of women in clinical trials: are we asking the right questions?  
http://www.whp-apsf.ca/pdf/clinicalTrialsEN.pdf
Addresses the issues evoked in considering the inclusion of women in clinical trials, highlighting especially where gender, even more than sex, is pertinent. (See Details)
Published: 2006
Women's cycles up for sale: neo-medicalization and women's reproductive health  
http://www.cwhn.ca/node/39520
Examines the medicalization of women's reproductive functions, including treating normal health cycles as problems or illnesses. (See Details)
Published: 2004
Marching to different drummers: health advocacy groups in Canada and funding from the pharmaceutical industry  
http://www.whp-apsf.ca/pdf/corpFunding.pdf
Explores drug company funding of health and disease advocacy groups. Argues that it creates a conflict of interest that needs to be recognized and addressed. (See Details)
Published: 2005
Strategies for public consultation and citizen access at the Therapeutic Product Programme, Health Protection Branch  
http://www.whp-apsf.ca/en/documents/pub-consult.html
Proposes recommendations in response to national public consultations held in 1998-99, to address proposed changes to federal health protection legislation. (See Details)
Published: 2000
CanWest's Charter Challenge on prescription drug advertising: a citizen's guide  
http://www.whp-apsf.ca/pdf/charter_challenge_en.pdf
Discusses the background to this legal case, the implications for Canadians, and what you can do. (See Details)
Published: 2006